Does TOFACITINIB Cause Blepharospasm? 596 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 596 reports of Blepharospasm have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
596
Reports of Blepharospasm with TOFACITINIB
0.4%
of all TOFACITINIB reports
552
Deaths
478
Hospitalizations
How Dangerous Is Blepharospasm From TOFACITINIB?
Of the 596 reports, 552 (92.6%) resulted in death, 478 (80.2%) required hospitalization, and 513 (86.1%) were considered life-threatening.
Is Blepharospasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 596 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Blepharospasm?
CETIRIZINE (735)
DESOXIMETASONE (730)
ADALIMUMAB (709)
TOCILIZUMAB (696)
RITUXIMAB (693)
NAPROXEN (692)
ERENUMAB-AOOE (689)
METHOTREXATE (689)
LEFLUNOMIDE (681)
SECUKINUMAB (677)
Which TOFACITINIB Alternatives Have Lower Blepharospasm Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN